Basis defective proliferation peripheral blood cells antibodies primary Sjogren syndrome cell proliferation peripheral blood samples primary secondary Sjogren syndrome patients PBMC proliferation low one-third primary Sjogren syndrome samples number cells similar primary secondary Sjogren syndrome normal PBMC samples depressed response anti-Ro+/La+ patients Experiments purified cells defect cell level responsible unresponsiveness Cell proliferation failure poor receptor mRNA expression receptor synthesis defective mitogenesis phorbol myristate acetate impaired protein activation Comparison PBMC proliferation treated untreated patients long-term study patients defect stable characteristic primary Sjogren syndrome patients pharmacological immunosuppression 